Advanced Treatment for Cancer and Tumor Suppression

Afinitor (everolimus) is a targeted therapy used to treat various types of cancer, including breast cancer, kidney cancer, and pancreatic neuroendocrine tumors. It works by inhibiting the mTOR pathway, which helps slow or stop the growth of cancer cells, offering patients an advanced approach to treatment.

Supports Recovery in Organ Transplant Patients

In addition to its cancer-fighting properties, Afinitor is also prescribed to prevent organ rejection in kidney and liver transplant patients. By regulating the body’s immune response, it helps ensure transplant success while reducing the risk of complications.

Easy-to-Take Oral Tablet for Daily Treatment

Afinitor comes in a convenient once-daily oral tablet, making it simple to incorporate into a treatment plan. When taken as directed, it provides continuous support in managing cancer progression and immune system regulation.